chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received Moderna dose #2 today as the shown on the vaccine card.  He received Moderna on 4/1/2021. The patient actually received Pfizer for his dose #1 per record. The patient was notified of the error and advised that he does not need to get another dose of Pfizer. He reported feeling well and no presence of adverse symptoms at this time. A new vaccine record will be mailed to the patient.
per patient's guardian, patient has joint pain. when tries to move the arm , patient experienced sharp pain. patient already contacted md
Headache; became very warm; started to breakout in a rash on arms, face, back of neck; Swelling occurred in the eye; Swelling occurred in the eye and lip area; became very anxious; Has a peanut allergy and felt that she was having a reaction.; This is a spontaneous report from a contactable consumer. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 02Apr2021 at 08:00, as a single dose for COVID-19 immunisation. Medical history included mild asthma and COVID-19 on unknown dates and peanut allergy. It was unknown if the patient received any medication within two weeks of vaccination and also unknown if received any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, unknown if the patient had been tested for COVID-19. On 04Apr2021 at 08:00, 48 hours after receipt of the second vaccine, the patient woke up with a headache. Drank water, ate salmon and rice made at home and felt better. Then on 04Apr2021, approximately 55 hours after vaccine, the patient went to play tennis indoors where she became very warm and started to breakout in a rash on arms, face and back of neck. On an unknown date in Apr2021, the patient experienced swelling in the eye and lip area and became very anxious. The patient has a peanut allergy and felt that she was having a reaction. However, she didn't see where she would have been in contact with peanuts and therefore thought it was due to the vaccine. Within an hour, as rash continued, the patient took Benadryl liquid form that reduced the rash. An hour later, the patient took a shower that also reduced the rash. No further action was taken. Therapeutic measures were taken as a result of the events and included treatment with benadryl liquid form. The clinical outcome of events headache, became very warm, rash on arms, face and back of neck, swelling in the eye and lip area, became very anxious and felt that she was having a reaction were recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt recv vax in 1995; in 1995 pt exp migraine headache.
2 cm firm red swelling in (L) thigh at site of Varicella and Hep A vaccines 7 days after vaccines given.
red arm, swollen,  pain   took benadryl and used ice pack. was sore for 1 week
Child developed marked fever 103.4 with erythematous rash and significant swelling at shot sites. Decreased sleeping, no eating. Has history of allergies to soy, milk & eggs.
Urticaria tx with Celadrin 4mg, antihistamine and Orapred.
Muscle ache particularly when raising arm began immediately and has continued to date. Worse now that second shot was given at same sight. Did not have 2nd shot in other arm as flu shot had been given there 2 days before. Second dose at same pharmacy at same site on 10/05/2018 NDC:58160-0819-12 resulted in increased arm ache plus 2 weeks of tiredness, headaches, and general body ache. Senior flu shot in right arm by same pharmacy 2 days before.
Lower Limb Cramps; Neurological Tingles in Legs and scalp; Scalp Tingling; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Lower Limb Cramps), PARAESTHESIA (Neurological Tingles in Legs and scalp) and PARAESTHESIA (Scalp Tingling) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MUSCLE SPASMS (Lower Limb Cramps), PARAESTHESIA (Neurological Tingles in Legs and scalp) and PARAESTHESIA (Scalp Tingling). At the time of the report, MUSCLE SPASMS (Lower Limb Cramps), PARAESTHESIA (Neurological Tingles in Legs and scalp) and PARAESTHESIA (Scalp Tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
I had a sore arm and got tired a little bit. The roof of my mouth felt like I ate a hot pizza. I used ice to sooth it and cough drops. It went away after a week. I did not see a doctor.
This spontaneous report as received from a consumer via Clinic refers to a currently 68 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 07-APR-2017, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 1 dose unit (lot # M036728, Expiry date was not reported) for prophylaxis (product storage error). There were no previous temperature excursions recorded. It was unknown if data logger was involved. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1801USA000166:
decreased range of motion, swelling in arm - Do not know time of course of Sx - Patient received medrol pak & PT for Tx
Patient given vaccine expired by 3 days based on 10 weeks at fridge temperature stability. Vaccine expired 7/12/2022 and given 7/15/2022.
Had first meal following the vaccine, had non-stop acid reflux, at the point of not wanting to eat.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 26Apr2021 at 16:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 18:00 the patient reported that after taking the first meal, followed by vaccination, had non-stop acid reflux and at the point  not wanting to eat. Therapeutic measures were taken as a result of reported events which included treatment with acid medication. Since the vaccination, the patient had not been tested for COVID-19.  The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event had non-stop acid reflux was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Narrative:  Patient COVID positive despite 3 doses of vaccine. COVID viral syndrome resulting in hospitalization from 2/8/2022 to 2/14/2022.
2 hours after injection, soreness in left arm around site that continued for 5 days (lessening each day). Evening of injection: headache, muscle aches, fever. In the morning, took 2 Extra Strength Tylenol. Symptoms abated, but felt tired for rest of day. 4 days later (Tuesday): Woke up with diarrhea; had to stay home from work. Tired for entire day. Treated with 3 doses of Pepto Bismol and symptoms abated.
SHAKING CHILLS; This spontaneous report received from a patient via media (JNJ) via a company representative and concerned a 67 year old of an unspecified sex, race and ethnicity. The patient's height and weight were not reported. The patient's concurrent conditions included: lifelong asthmatic, respiratory condition and breast cancer survivor. The patient never had Covid-19 in the entire time. The patient received first shot of covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, within a few hours of the first vaccine the patient had about 30 minutes of shaking chills. It was reported that "I took your CoVID vaccine for the first shot and then the first booster. I then switched to Pfizer and will do the additional booster when it is available. I know some people have issues but I had pretty much no side effects or adverse effects for that matter. I was 67 years old and a lifelong asthmatic with an additional respiratory condition and a breast cancer survivor. I had about 30 minutes of shaking chills within a few hours of the first vaccine and that was it. Just to give you some positive feedback. And. BTW, I have never had CoVID-19 this entire time" (dose number in series 1). The patient also received the first booster of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin and batch number were not reported, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis.  It was unknown whether the patient had any adverse events following vaccination with first booster of covid-19 vaccine ad26.cov2.s (dose number in series 2).  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shaking chills. This report was non-serious.
severe pain throughout the body, unable to move from laying down. Initiated flare of RA symptoms that have not fully resolved (particularly in hands [exacerbation] and elbow [new site]) - started Friday after vaccination, and was unable to move well or focus until Monday morning.   Also had a large welt at the injection site that took 10 days to resolve - affected movement, was extremely hot and painful to touch.
patient states that immediately following administration of covid vaccine on 2/5  he began to experience profuse sweating, dizziness and nausea. He went home and then went to the ED for syncope on 2/6. Prior to ED, patient states that he became so dizzy that he lost control of his head and it slammed on the table he was sitting at leading him to go to the ED. The ED note is without mention of the vaccine. However, when pt saw me on  2/9, he states that all of his symptoms were r/t the vaccine. He left ama from the ED who wanted to admit him for a cardiac eval. I did not witness administration nor did I know patient prior to visit. I just saw him following his ED visit. It is not my intent to mislead the Department of Human and Health Services, I am simply reporting what the patient told me.
PATIENT DID NOT QUALIFY FOR 4TH DOSE, BUT 4TH DOSE GIVEN. PATIENT HAS NOT EXPERIENCED ANY ADVERSE EFFECTS.
This was 4th covid vaccine (second booster) but all others were Pfizer - this was the first Moderna.  A little over 2 weeks I started itching very badly all over my body.  Been to doctors and dermotoligsts and taking antihistamines, steroids and creams.  I am still itchy all the time with scabs all over my body including my head.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 22-MAY-2007, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-JUN-2016, the patient was treated at a clinic for a blistering vesicular outbreak which was then diagnosed as herpes zoster or shingles. The patient has been prescribed NEURONTIN, NORCO for management of her painful symptoms and excruciating pain.  As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
TINGLING SENSATION OF PINS AND NEEDLE; HEADACHE; FEVER; MUSCULAR ACHES; ITCHING; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced tingling sensation of pins and needle, headache, fever, muscular aches, and itching. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, fever, muscular aches, itching and tingling sensation of pins and needle was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment not required per standard procedure as the case is assessed as non-serious.
started vomiting around 10PM;lasted 3-4hrs mom called ER & was told to try Pedialyte or sprite;mom gave pt sprite & pt did not vomit p/that;no fever;did not contact MD;
Received the vaccine on 12/29/2020 and tested positive for Covid19 on January 4, 2021
pt recvd vax & 10 hrs later started shaking-lips got bluish, ?respiratory difficulty, dad thinks may have stopped breathing; This resolved p/2 mins (eyes also rolled back), saliva out of mouth; dad states pt felt feverish @ this time;
dizziness at first that lasted half hour along with heart rate increase, and slight headache. an hour after injection, body aches, lethargic, a stronger headache, injection sight (left arm) was very sore. Later, aprox 3-4 hours,  as  symptoms subsided  (headache, body aches, lethargic, heart rate returned to normal a few hours after injection), a new symptoms arise with numbness in my left leg from the knee down to my foot ,injection sight  and arm soreness, and the back of my throat felt "funny" and dry it lasted aprox an hour (fyi: drank plenty of water throughout these symptoms).  I took my normal medication. Went to sleep. Woke up and numbness was gone.  Injection sight is still a bit sore but not as intense. I am feeling well today with little or no symptoms at all.
8JUL96 pt noticed inflammation of wrist, pain, redness, lack of mobility & loss of strength in wrist;
Pt started vomiting not long after receiving vaccination and called office to inform doctor. A prescription was called in for PHENERGAN and pt is doing much better, no more vomiting. 11/5/09 OB records received for dates 6/30/09 to 10/9/09.EDC: 2/15/09. G3P1 No information provided pertaining to H1N1 vaccine.
Left thigh red and warm to touch.  Area hard and approximately 13.5cm x 9.5cm.  Dad states symptoms started 07/29/2003 in PM.
Localized hard knot in deltoid muscle, swelling of the entire arm and hand, pain in arm and shoulder area and scapula, temperature in arm.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination. No Medical History information was reported. On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 10-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. This case was linked to MOD-2022-448109 (Patient Link).
Information has been received from a nurse practitioner (NP), via a company representative, concerning a female patient (age unspecified), who on an unknown date was vaccinated with a dose, 0.5ml, of Gardasil (Lot # "unavailable"). The NP reported that the patient developed a "vaso-vagal condition" following the vaccination. No further details were provided. At the time of the this report, the outcome of the event was unknown. The patient sought unspecified medical attention. Additional information has been requested.
Fever, swollen glands, sore throat, ear pain, itchy, trouble breathing, listless, achy body, confused & spacey, forgetful, emotional, irritable, loss of appetite, laryngitis, stomach pain, cough.
Information has been received from a nurse concerning a patient who was vaccinated with a 0.5 ml dose of Pneumovax 23 (lot # 654982/0675F). Subsequently the patient experienced severe localized reactions which included welts and a rash on the extremity that was vaccinated, but not necessarily at the injection site. The reaction was reported "from the shoulder to the elbow." It was reported that there was "firm tissue" that extended from the elbow to the wrist. The patient was treated with antibiotics and antihistamines. It was reported that the lot # would not be used and there was concern expressed regarding the lot number. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the government agency and was released by the regulatory agency. Additional information has been requested.
57 y.o. female with PMH significant for multiple comorbidities including history of obstructive sleep apnea, chronic left shoulder pain s/p surgery in the past, right carpal tunnel surgery recently, came into the ER from home with complaint of shortness of breath.  Patient was in her usual state of health at least until last Tuesday when she got her second Covid shot, starting Wednesday she started to have pleuritic chest pain, followed by shortness of breath.  Shortness of breath progressively was getting worse, increased on exertion, subsequently was short of breath at rest and even on talking.  Patient also noted frothy sputum tinged with blood.  Secondary to above patient initially had a televisit with PCP early this morning and was instructed to come to ED. On further questioning patient denies complains of associated nausea, vomiting, diarrhea abdominal pain.  Denies any fever, chills. Denies any other complaints of melena or hematochezia  In the ED further work-up including a CT angio pulmonary showed evidence of PE.  pt was treated and discharged the next day on Xarelto.  On 6/13/21, pt presented back to ED with Chest heaviness and shortness of breath  for 3 days Patient with recent diagnosis of unexplained pulmonary embolism. She was loaded with Xarelto for 21 days and subsequently is taking the full daily dose now. Ultrasound of legs was not performed to her initial hospitalization. CTA was repeated today and does not show new pulmonary emboli. CTA on May 17 showed small pulmonary emboli in the lobular in segment mental left lower lobe pulmonary arteries as well as a segmental right middle lobe and lingular pulmonary arteries. She had a left pleural effusion. This was later tapped. Cardiac echo obtained on 518 showed a small pericardial effusion. LVEF at that time was normal. RV systolic pressure was estimated at 36 mmHg. This is only slightly elevated. The patient is normally very active and wanted to get back to her normal activities. On Thursday she did some exercise and subsequent developed her current symptoms of chest heaviness and shortness of breath. She backed off on the exercise. She now came to the emergency room. Troponin is negative. EKG has nonspecific changes. Repeat CTA is now not showing pulmonary embolism. There is no significant pericardial effusion or pleural effusion seen. No evidence of recurrent pulmonary emboli and pt was discharged home.
2/22/2020 6:30 p.m. arm pain, chills evening 2/23/2020 3:00 a.m. fever, little nausea, chills all night chills all night, poor sleep 2/23/2020  5:00 a.m. aches and fever, took aspirin, felt more comfortable within an hour. 2/23/2020  felt weak and tired until 4:00 p.m.  Arm very sore and red. 2/24/202 until 2/25/2020 arm sore
After receiving the vaccine, she began to complain of tingling of the hands and feet, and feeling of feeling faint. She was taken over to a gurney where she was laid down and had her vitals taken. BP 101/53, HR 117, O2 100% initially. After having her breath slowly and deeply for about 10 minutes, she her vital signs normalized and she denied any abnormal feelings. Final BP was 120/69, HR 86, O2 100%.
soreness at the injection site.; felt like he had a fever; Could barely move around; . He is now past 6 months and has not gotten the 2nd dose yet; fatigued such that he could barely move around; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 13th August 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, the patient received the 2nd dose of Shingrix. On 13th August 2019, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced fatigue. On an unknown date, the patient experienced injection site pain, feeling hot, movements reduced and incomplete course of vaccination. On an unknown date, the outcome of the fatigue was recovered/resolved and the outcome of the injection site pain, feeling hot, movements reduced and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the fatigue, injection site pain, feeling hot and movements reduced to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and  within 3-4 hours he felt very fatigued such that he could barely move around.  The fatigue lasted about 24 hours before resolving. The patient also felt like he had a fever, but the thermometer did not show a fever. He had some soreness at the injection site.  Till the time of reporting the patient did not received 2nd dose of Shingrix which led to incomplete course of administration. Reporter consented to follow up. This case has been linked with case US2020029075, reported by same reporter.
Stiffness and staring for few minutes. Happened few times for few days since the day of vaccination.
Rednss warmth and swelling at injection site. Low grade fever, malaise and nausea
Pt. received a Hepatitis A vaccine in (L) deltoid and a Typhoid Vi vaccine in (R) deltoid. After the second vaccine was administered pt. complained of feeling dizzy and warm. Place pt. in a reclined position. Offered pt juice. Pt. stated she had eaten a small breakfast and no lunch. Placed cold pack behind neck, for 10 minutes, instructed pt. to rest an additional 10 minutes was able to stand up without dizziness and walk out of clinic by 2 pm (1400).